Profound Medical Corp. (PROF) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -8.46M | -6.66M | -9.48M | -14.07M | -8.28M | -5.64M | -6.83M | -6.22M | -4.53M | -7.02M | -4.34M | -5.12M |
| Operating CF Margin % | -160.82% | -111.4% | -179.24% | -636.33% | -316.02% | -105.92% | -178.24% | -278.56% | -314.73% | -263.61% | -251.04% | -319.54% |
| Operating CF Growth % | -2.19% | -18.01% | -38.88% | -126.23% | -82.89% | 19.6% | -57.35% | -21.49% | 22.22% | -5.96% | 24.62% | 8.06% |
| Net Income | -6.96M | -8.3M | -7.89M | -15.95M | -10.72M | -5.33M | -9.37M | -6.92M | -6.58M | -8.91M | -5.56M | -7.36M |
| Depreciation & Amortization | 98.61K | 110.67K | 145.37K | 143.32K | 163K | 76K | 214K | 234K | 250K | 299K | 287K | 277K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 989K | 442K | 604K | 768K | 767K | 907K | 727K | 842K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.09M | 1.41M | 1.74M | 1.39M | 39K | -60K | 60K | 45K | 90K | 477K | 179K | 435K |
| Working Capital Changes | -2.7M | 126.47K | -3.48M | 355.26K | 1.25M | -766K | 1.66M | -347K | 949K | 209K | 33K | 682K |
| Change in Receivables | -2.21M | 749.54K | -3.39M | 1.39M | 1.09M | -124K | 297K | -841K | 1.32M | -801K | -128K | 573K |
| Change in Inventory | -982.2K | -231.14K | 151.81K | -1.78M | -984K | 475K | 344K | 12K | -180K | 407K | 137K | 139K |
| Change in Payables | 306.69K | 40.46K | -212.08K | 247.93K | 300K | 653K | 676K | 63K | -570K | 1.19M | -169K | 355K |
| Cash from Investing | 0 | -246.24K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | -246.24K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | 4.12% | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 75K | 42.15M | 2.27K | 5.47K | -290K | 35.65M | -592K | -603K | 20.46M | -491K | -189K | 0 |
| Debt Issued (Net) | 0 | -1.03M | 2.27K | 5.47K | -290K | -523K | -592K | -604K | -623K | -495K | -191K | -239K |
| Equity Issued (Net) | 0 | 43.19M | 0 | 0 | 0 | 39.17M | 0 | 0 | 22.94M | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 75K | 0 | 0 | 0 | 0 | -2.99M | 0 | 1K | -1.86M | 4K | 2K | 239K |
| Net Change in Cash | -9.15M | 34.81M | -10.47M | -11.16M | -8.48M | 27.79M | -6.96M | -7.1M | 14.97M | -7.41M | -5.65M | -3.71M |
| Free Cash Flow | -8.46M | -6.84M | -9.48M | -14.07M | -8.28M | -5.64M | -6.83M | -6.22M | -4.53M | -7.02M | -4.34M | -5.12M |
| FCF Margin % | -160.82% | -114.39% | -179.24% | -636.33% | -316.02% | -105.92% | -178.24% | -278.56% | -314.73% | -263.61% | -251.04% | -319.54% |
| FCF Growth % | -2.19% | -21.19% | -38.88% | -126.23% | -82.89% | 19.6% | -57.35% | -21.49% | 22.22% | -5.96% | 24.62% | 8.06% |
| FCF per Share | -0.23 | -0.22 | -0.31 | -0.47 | -0.28 | -0.22 | -0.28 | -0.25 | -0.19 | -0.33 | -0.20 | -0.24 |
| FCF Conversion (FCF/Net Income) | 1.22x | 0.81x | 1.19x | 0.90x | 0.77x | 0.74x | 0.54x | 0.90x | 0.69x | 0.61x | 0.78x | 0.70x |
| Interest Paid | 0 | 0 | 0 | 0 | 56K | 0 | 133K | 148K | 159K | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 11K | 0 | 38K | 160K | 14K | 0 | 0 | 0 |